Business Description
hVIVO PLC
ISIN : GB00B9275X97
Compare
Compare
Traded in other countries / regions
HVO.UKCRO.GermanyHVO.IrelandOPORF.USA IPO Date
2012-12-12Description
hVIVO PLC is a European-focused, rare, and orphan drug consulting services platform. The principal activity of the Group is that of a rapidly growing specialist CRO pharmaceutical services company, which involves the testing of vaccines and antivirals using human-challenge clinical trials. The group is also engaged in Venn Life Sciences' Clinical Research Division, providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.95 | |||||
| Equity-to-Asset | 0.41 | |||||
| Debt-to-Equity | 0.37 | |||||
| Debt-to-EBITDA | 0.89 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 4.24 | |||||
| Beneish M-Score | -1.63 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 34.1 | |||||
| 3-Year FCF Growth Rate | 53.3 | |||||
| 3-Year Book Growth Rate | 14.9 | |||||
| Future 3-5Y Total Revenue Growth Rate | 10.12 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.24 | |||||
| 9-Day RSI | 42.19 | |||||
| 14-Day RSI | 44.78 | |||||
| 6-1 Month Momentum % | 44.47 | |||||
| 12-1 Month Momentum % | 56.46 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.48 | |||||
| Quick Ratio | 1.47 | |||||
| Cash Ratio | 1.05 | |||||
| Days Inventory | 6.89 | |||||
| Days Sales Outstanding | 47.21 | |||||
| Days Payable | 30.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.73 | |||||
| Forward Dividend Yield % | 0.73 | |||||
| 5-Year Yield-on-Cost % | 0.73 | |||||
| 3-Year Average Share Buyback Ratio | -0.6 | |||||
| Shareholder Yield % | -2.52 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 56.87 | |||||
| Operating Margin % | 18.42 | |||||
| Net Margin % | 28.76 | |||||
| FCF Margin % | 21.52 | |||||
| ROE % | 63.45 | |||||
| ROA % | 25.97 | |||||
| ROIC % | 33.4 | |||||
| ROC (Joel Greenblatt) % | 125.41 | |||||
| ROCE % | 36.59 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 11.13 | |||||
| Forward PE Ratio | 18.35 | |||||
| PE Ratio without NRI | 20.54 | |||||
| Price-to-Owner-Earnings | 8.34 | |||||
| PS Ratio | 3.26 | |||||
| PB Ratio | 5.34 | |||||
| Price-to-Tangible-Book | 7.06 | |||||
| Price-to-Free-Cash-Flow | 15.71 | |||||
| Price-to-Operating-Cash-Flow | 10.68 | |||||
| EV-to-EBIT | 14.39 | |||||
| EV-to-Forward-EBIT | 17.03 | |||||
| EV-to-EBITDA | 11.61 | |||||
| EV-to-Forward-EBITDA | 11.8 | |||||
| EV-to-Revenue | 2.91 | |||||
| EV-to-Forward-Revenue | 2.62 | |||||
| EV-to-FCF | 13.03 | |||||
| Price-to-Projected-FCF | 3.14 | |||||
| Price-to-Median-PS-Value | 2.02 | |||||
| Price-to-Graham-Number | 2.57 | |||||
| Earnings Yield (Greenblatt) % | 6.95 | |||||
| FCF Yield % | 6.45 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
hVIVO PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | 56.043 | ||
| EPS (TTM) (£) | 0.024 | ||
| Beta | 3.35 | ||
| Volatility % | 50.28 | ||
| 14-Day RSI | 44.78 | ||
| 14-Day ATR (£) | 0.01231 | ||
| 20-Day SMA (£) | 0.286675 | ||
| 12-1 Month Momentum % | 56.46 | ||
| 52-Week Range (£) | 0.14 - 0.32 | ||
| Shares Outstanding (Mil) | 680.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
hVIVO PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
hVIVO PLC Stock Events
| Event | Date | Price(£) | ||
|---|---|---|---|---|
| No Event Data | ||||
hVIVO PLC Frequently Asked Questions
What is hVIVO PLC(LSE:HVO)'s stock price today?
The current price of LSE:HVO is £0.28. The 52 week high of LSE:HVO is £0.32 and 52 week low is £0.14.
When is next earnings date of hVIVO PLC(LSE:HVO)?
The next earnings date of hVIVO PLC(LSE:HVO) is 2024-09-12 Est..
Does hVIVO PLC(LSE:HVO) pay dividends? If so, how much?
The Dividend Yield %  of hVIVO PLC(LSE:HVO) is 0.73% (As of Today), Highest Dividend Payout Ratio of hVIVO PLC(LSE:HVO) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of hVIVO PLC(LSE:HVO) is 0.73%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers